Bone vs. fat: Embryonic origin of progenitors determines response to androgen in adipocytes and osteoblasts

Bone

Volumn 49, Issue 4, 2011, Pages 662-672

  Wiren, Kristine M ^a,b   Hashimoto, Joel G ^a,b   Semirale, Anthony A ^a,b   Zhang, Xiao Wei ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Androgen; Mesenchymal stem cell; Neural crest; Periosteum; Testosterone

Indexed keywords

ALKALINE PHOSPHATASE; ANDROGEN; ANDROGEN RECEPTOR; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 15; BONE MORPHOGENETIC PROTEIN 6; DICKKOPF 1 PROTEIN; EPHRIN B3; FIBROBLAST GROWTH FACTOR 4; HEPATOCYTE NUCLEAR FACTOR 1BETA; HERMES ANTIGEN; MESSENGER RNA; OSTEOCALCIN; SMAD2 PROTEIN; TRANSCRIPTION FACTOR PITX2; TRANSCRIPTION FACTOR SIX3; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY FAT; BONE; BONE DEVELOPMENT; BONE GROWTH; BONE MINERALIZATION; CALVARIA; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENOTYPE; MALE; MESENCHYMAL STEM CELL; MESODERM; MOUSE; NERVE FIBER TRANSPORT; NEURAL CREST CELL; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; PERIOSTEUM; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SKULL; STEM CELL; UPREGULATION;

ADIPOCYTES; ADIPOSITY; ANABOLIC AGENTS; ANDROGENS; ANIMALS; BONE AND BONES; CELLS, CULTURED; EMBRYONIC STEM CELLS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, TRANSGENIC; NEURAL CREST; OSTEOBLASTS; OSTEOGENESIS; PERIOSTEUM; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKULL;

EID: 80052293939     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.06.010     Document Type: Article

References (54)

1. Vanderschueren D., Gaytant J., Boonen S., Venken K. Androgens and bone. Curr Opin Endocrinol Diabetes Obes 2008, 15:250-254.
2. Vignozzi L., Morelli A., Filippi S., Maggi M., Forti G. Male pubertal development: role of androgen therapy on bone mass and body composition. J Endocrinol Invest 2011, 33:27-32.
3. Frenkel B., Hong A., Baniwal S., Coetzee G., Ohlsson C., Khalid O., et al. Regulation of adult bone turnover by sex steroids. J Cell Physiol 2010, 224:305-310.
4. Wiren K. Androgens and bone growth: it's location, location, location. Curr Opin Pharmacol 2005, 5:626-632.
5. Carnevale V., Romagnoli E., Cipriani C., Del Fiacco R., Piemonte S., Pepe J., et al. Sex hormones and bone health in males. Arch Biochem Biophys 2010, 503:110-117.
6. Callewaert F., Sinnesael M., Gielen E., Boonen S., Vanderschueren D. Skeletal sexual dimorphism: relative contribution of sex steroids, GH-IGF1, and mechanical loading. J Endocrinol 2010, 207:127-134.
7. Callewaert F., Venken K., Kopchick J., Torcasio A., van Lenthe G., Boonen S., et al. Sexual dimorphism in cortical bone size and strength but not density is determined by independent and time-specific actions of sex steroids and IGF-1: evidence from pubertal mouse models. J Bone Miner Res 2010, 25:617-626.
8. Wiren K.M., Zhang X.W., Toombs A.R., Kasparcova V., Gentile M.A., Harada S., et al. Targeted overexpression of androgen receptor in osteoblasts: unexpected complex bone phenotype in growing animals. Endocrinology 2004, 145:3507-3522.
9. Wiren K.M., Semirale A.A., Zhang X.W., Woo A., Tommasini S.M., Price C., et al. Targeting of androgen receptor in bone reveals a lack of androgen anabolic action and inhibition of osteogenesis. A model for compartment-specific androgen action in the skeleton. Bone 2008, 43:440-451.
10. Idan A., Griffiths K., Harwood D., Seibel M., Turner L., Conway A., et al. Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial. Ann Intern Med 2010, 153:621-632.
11. Kenny A., Kleppinger A., Annis K., Rathier M., Browner B., Judge J., et al. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty. J Am Geriatr Soc 2010, 58:1134-1143.
12. Benito M., Vasilic B., Wehrli F.W., Bunker B., Wald M., Gomberg B., et al. Effect of testosterone replacement on trabecular architecture in hypogonadal men. J Bone Miner Res 2005, 20:1785-1791.
13. Wang C., Cunningham G., Dobs A., Iranmanesh A., Matsumoto A., Snyder P., et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004, 89:2085-2098.
14. Wiren K., Semirale A., Hashimoto J., Zhang X. Signaling pathways implicated in androgen regulation of endocortical bone. Bone 2010, 46:710-723.
15. Schindeler A., Liu R., Little D. The contribution of different cell lineages to bone repair: exploring a role for muscle stem cells. Differentiation 2009, 77:12-18.
16. Leucht P., Kim J., Amasha R., James A., Girod S., Helms J. Embryonic origin and Hox status determine progenitor cell fate during adult bone regeneration. Development 2008, 135:2845-2854.
17. Bhasin S. Regulation of body composition by androgens. J Endocrinol Invest 2003, 26:814-822.
18. Matsumoto A. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 2002, 57:M76-M99.
19. Hartgens F., Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med 2004, 34:513-554.
20. Seidell J., Bjorntorp P., Sjostrom L., Kvist H., Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990, 39:897-901.
21. Bassil N., Alkaade S., Morley J. The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag 2009, 5:427-448.
22. Mauras N., Hayes V., Welch S., Rini A., Helgeson K., Dokler M., et al. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab 1998, 83:1886-1892.
23. Woodhouse L.J., Gupta N., Bhasin M., Singh A.B., Ross R., Phillips J., et al. Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J Clin Endocrinol Metab 2004, 89:718-726.
24. Nedungadi T., Clegg D. Sexual dimorphism in body fat distribution and risk for cardiovascular diseases. J Cardiovasc Transl Res 2009, 2:321-327.
25. Semirale A., Zhang X., Wiren K. Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation. J Cell Biochem 2011, 112:1773-1786.
26. Nagoshi N., Shibata S., Kubota Y., Nakamura M., Nagai Y., Satoh E., et al. Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. Cell Stem Cell 2008, 2:392-403.
27. Billon N., Monteiro M., Dani C. Developmental origin of adipocytes: new insights into a pending question. Biol Cell 2008, 100:563-575.
28. Hashimoto J.G., Beadles-Bohling A.S., Wiren K.M. Comparison of RiboGreen and 18S rRNA quantitation for normalizing real-time RT-PCR expression analysis. Biotechniques 2004, 36(54-6):58-60.
29. Gross J., Hanken J. Review of fate-mapping studies of osteogenic cranial neural crest in vertebrates. Dev Biol 2008, 317:389-400.
30. Yoshiko Y., Oizumi K., Hasegawa T., Minamizaki T., Tanne K., Maeda N., et al. A subset of osteoblasts expressing high endogenous levels of PPARgamma switches fate to adipocytes in the rat calvaria cell culture model. PLoS One 2010, 5:e11782.
31. Nombela-Arrieta C., Ritz J., Silberstein L. The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol 2011, 12:126-131.
32. Allen M., Hock J., Burr D. Periosteum: biology, regulation, and response to osteoporosis therapies. Bone 2004, 35:1003-1012.
33. Seeman E. Periosteal bone formation-a neglected determinant of bone strength. N Engl J Med 2003, 349:320-323.
34. Fan W., Crawford R., Xiao Y. Structural and cellular differences between metaphyseal and diaphyseal periosteum in different aged rats. Bone 2008, 42:81-89.
35. McBride S., Dolejs S., Brianza S., Knothe U., Knothe Tate M. Net change in periosteal strain during stance shift loading after surgery correlates to rapid de novo bone generation in critically sized defects. Ann Biomed Eng 2011, 39:1570-1581.
36. Callewaert F., Bakker A., Schrooten J., Van Meerbeek B., Verhoeven G., Boonen S., et al. Androgen receptor disruption increases the osteogenic response to mechanical loading in male mice. J Bone Miner Res 2010, 25:124-131.
37. Bonewald L. Mechanosensation and transduction in osteocytes. Bonekey Osteovision 2006, 3:7-15.
38. Santos A., Bakker A., Klein-Nulend J. The role of osteocytes in bone mechanotransduction. Osteoporos Int 2009, 20:1027-1031.
39. Wiren K.M., Toombs A.R., Semirale A.A., Zhang X. Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio. Bone 2006, 38:637-651.
40. Thorogood P. In vitro studies on skeletogenic potential of membrane bone periosteal cells. J Embryol Exp Morphol 1979, 54:185-207.
41. Goss R., Powel R. Induction of deer antlers by transplanted periosteum. I. Graft size and shape. J Exp Zool 1985, 235:359-373.
42. Li C., Mackintosh C., Martin S., Clark D. Identification of key tissue type for antler regeneration through pedicle periosteum deletion. Cell Tissue Res 2007, 328:65-75.
43. Li C., Littlejohn R., Corson I., Suttie J. Effects of testosterone on pedicle formation and its transformation to antler in castrated male, freemartin and normal female red deer (Cervus elaphus). Gen Comp Endocrinol 2003, 131:21-31.
44. Bartos L., Schams D., Bubenik G. Testosterone, but not IGF-1, LH, prolactin or cortisol, may serve as antler-stimulating hormone in red deer stags (Cervus elaphus). Bone 2009, 44:691-698.
45. Kuzmova E., Bartos L., Kotrba R., Bubenik G. Effect of different factors on proliferation of antler cells, cultured in vitro. PLoS One 2011, 6:e18053.
46. Quarto N., Behr B., Li S., Longaker M. Differential FGF ligands and FGF receptors expression pattern in frontal and parietal calvarial bones. Cells Tissues Organs 2009, 190:158-169.
47. Quarto N., Wan D., Kwan M., Panetta N., Li S., Longaker M. Origin matters: differences in embryonic tissue origin and Wnt signaling determine the osteogenic potential and healing capacity of frontal and parietal calvarial bones. J Bone Miner Res 2010, 25:1680-1694.
48. Helms J., Amasha R., Leucht P. Bone voyage: an expedition into the molecular and cellular parameters affecting bone graft fate. Bone 2007, 41:479-485.
49. Ray R., Novotny N., Crisostomo P., Lahm T., Abarbanell A., Meldrum D. Sex steroids and stem cell function. Mol Med 2008, 14:493-501.
50. Garza L., Yang C., Zhao T., Blatt H., Lee M., He H., et al. Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200-rich and CD34-positive hair follicle progenitor cells. J Clin Invest 2011, 121:613-622.
51. Yu H., Kumar S., Kossenkov A., Showe L., Xu X. Stem cells with neural crest characteristics derived from the bulge region of cultured human hair follicles. J Invest Dermatol 2010, 130:1227-1236.
52. Knothe U., Springfield D. A novel surgical procedure for bridging of massive bone defects. World J Surg Oncol 2005, 3:7.
53. Fuchs B., Steinmann S., Bishop A. Free vascularized corticoperiosteal bone graft for the treatment of persistent nonunion of the clavicle. J Shoulder Elbow Surg 2005, 14:264-268.
54. Minear S., Leucht P., Miller S., Helms J. rBMP represses Wnt signaling and influences skeletal progenitor cell fate specification during bone repair. J Bone Miner Res 2010, 25:1196-1207.